Author
|
Year
|
Type of study
|
Number of patients
|
Purpose of study
|
Result
|
Conclusion
|
Ataş et al. [3]
|
2017
|
Case-control
|
63
|
To investigate the association of metabolic syndrome and vitiligo
|
Poor clinical features of vitiligo were found to be an independent factor for metabolic syndrome
|
Increased risk of developing metabolic syndrome in vitiligo
|
Azzazi et al. [12]
|
2020
|
Case-control
|
50
|
To determine the increased risk of cardiovascular events in vitiligo
|
Increased levels of H2O2 and MDA and decreased levels of TAC. Increased CIMT level
|
Increased risk of developing dyslipidemia and atherosclerosis, which increases the risk of developing cardiovascular diseases
|
Sinha et al. [13]
|
2019
|
Case-control
|
75
|
To assess the association of metabolic syndrome with vitiligo
|
A significant difference in HDL and TG in patients compared to controls
|
Metabolic syndrome was associated with vitiligo
|
Khan et al. [15]
|
2009
|
Case-control
|
30
|
To determine the level of antioxidants in patients
|
Increased levels of MDA, decreased levels of SOD, GPx, vitamin C, vitamin E, and TAC
|
Oxidative stress plays a vital role in melanocyte destruction leading to the development of vitiligo
|
Bhatti et. al. [16]
|
2017
|
Narrative review
|
-
|
To ascertain the role of mitochondrial dysfunction and oxidative stress in metabolic disorders
|
-
|
Mitochondrial dysfunctions are involved in aging, cancer, metabolic syndrome, and neurodegenerative disorders
|